Form D · Biotechnology

Inform Genomics, Inc.

Boston, MA · CIK 0001537988

Offering snapshot reported Nov 10, 2016 · SEC filing

Reported sold
Yet to sell
Offering amount: $1.45M
Investors reported
0
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Yet to occur
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 10, 2016InitialYet to sellNo comparison0SEC filing
Oct 7, 2015InitialYet to sellNo comparison0SEC filing
Oct 7, 2015InitialYet to sellNo comparison0SEC filing
Jan 12, 2015Amendment$1,726,949$510,157vs Feb 24, 201415SEC filing
Jul 3, 2014Amendment$1,363,672$146,880vs Feb 24, 201411SEC filing
Feb 24, 2014Initial$1,216,792No comparison7SEC filing
Dec 22, 2011Initial$1,325,000No comparison12SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-274264

Source: Form D, filed Nov 10, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Donald A. Berry Director
William C. Brown Director, Executive
Carl De Moor Executive
Andrew Ferrara Director
Edward G. Fey Director, Promoter
William Jordan Director
Edward B Rubenstein Director, Executive, Promoter
William Shields Director, Executive
Steve Sonis Director
Reed Tuckson Director
Susan M. Weidner Executive, Promoter

Issuer details

Industry: Biotechnology (See others in industry)

Address:
101 Federal Street Suite 1900
Boston, MA, 02110